Daily aspirin improves colorectal cancer survival

The meta-analysis showed that aspirin use after diagnosis reduced all-cause mortality for patients with CRC by 16%, and people who had the PIK3CA mutation and increased levels of COX-2 expression in the primary tumours seemed to benefit the most.